ID   CO2A1_RAT               Reviewed;        1419 AA.
AC   P05539; Q63123; Q63565; Q78DY3;
DT   01-NOV-1988, integrated into UniProtKB/Swiss-Prot.
DT   06-DEC-2005, sequence version 2.
DT   24-JUL-2024, entry version 151.
DE   RecName: Full=Collagen alpha-1(II) chain {ECO:0000250|UniProtKB:P02458};
DE   AltName: Full=Alpha-1 type II collagen {ECO:0000250|UniProtKB:P02458};
DE   Contains:
DE     RecName: Full=Collagen alpha-1(II) chain {ECO:0000250|UniProtKB:P02458};
DE   Contains:
DE     RecName: Full=Chondrocalcin {ECO:0000250|UniProtKB:P02458};
DE   Flags: Precursor;
GN   Name=Col2a1 {ECO:0000312|RGD:2375};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Bone;
RA   Urabe K., Sarkar G., Bolander M.E.;
RT   "Complete rat type II collagen cDNA sequence.";
RL   Submitted (OCT-1995) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-122.
RX   PubMed=6094525; DOI=10.1016/s0021-9258(18)89796-4;
RA   Kohno K., Martin G.R., Yamada Y.;
RT   "Isolation and characterization of a cDNA clone for the amino-terminal
RT   portion of the pro-alpha 1(II) chain of cartilage collagen.";
RL   J. Biol. Chem. 259:13668-13673(1984).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-29.
RX   PubMed=2984204; DOI=10.1016/s0021-9258(18)89284-5;
RA   Kohno K., Sullivan M., Yamada Y.;
RT   "Structure of the promoter of the rat type II procollagen gene.";
RL   J. Biol. Chem. 260:4441-4447(1985).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 370-422.
RC   STRAIN=DA; TISSUE=Cartilage;
RX   PubMed=8046350; DOI=10.1084/jem.180.2.745;
RA   Michaelson E., Malmstrom V., Reis S., Engstrom A., Burkhardt H.,
RA   Holmdahl R.;
RT   "T-cell recognition of carbohydrates on type II collagen.";
RL   J. Exp. Med. 180:745-749(1994).
RN   [5]
RP   HYDROXYLATION AT PRO-591; PRO-600; PRO-602; PRO-603; PRO-606; PRO-839;
RP   PRO-840; PRO-846; PRO-852; PRO-1076; PRO-1113; PRO-1118; PRO-1119;
RP   PRO-1133; PRO-1134; PRO-1137; PRO-1139; PRO-1140 PRO-1143; PRO-1145 AND
RP   PRO-1146, TISSUE SPECIFICITY, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=21757687; DOI=10.1074/jbc.m111.267906;
RA   Fernandes R.J., Farnand A.W., Traeger G.R., Weis M.A., Eyre D.R.;
RT   "A role for prolyl 3-hydroxylase 2 in post-translational modification of
RT   fibril-forming collagens.";
RL   J. Biol. Chem. 286:30662-30669(2011).
CC   -!- FUNCTION: Type II collagen is specific for cartilaginous tissues. It is
CC       essential for the normal embryonic development of the skeleton, for
CC       linear growth and for the ability of cartilage to resist compressive
CC       forces.
CC   -!- SUBUNIT: Homotrimers of alpha 1(II) chains.
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix {ECO:0000255|PROSITE-ProRule:PRU00793}.
CC   -!- TISSUE SPECIFICITY: Expressed in chondrocytes.
CC       {ECO:0000269|PubMed:21757687}.
CC   -!- DOMAIN: The C-terminal propeptide, also known as COLFI domain, have
CC       crucial roles in tissue growth and repair by controlling both the
CC       intracellular assembly of procollagen molecules and the extracellular
CC       assembly of collagen fibrils. It binds a calcium ion which is essential
CC       for its function (By similarity). {ECO:0000250}.
CC   -!- PTM: Contains mostly 4-hydroxyproline. Prolines at the third position
CC       of the tripeptide repeating unit (G-X-P) are 4-hydroxylated in some or
CC       all of the chains. {ECO:0000269|PubMed:21757687}.
CC   -!- PTM: Contains 3-hydroxyproline at a few sites. This modification occurs
CC       on the first proline residue in the sequence motif Gly-Pro-Hyp, where
CC       Hyp is 4-hydroxyproline. {ECO:0000269|PubMed:21757687}.
CC   -!- PTM: Lysine residues at the third position of the tripeptide repeating
CC       unit (G-X-Y) are 5-hydroxylated in some or all of the chains.
CC       {ECO:0000305}.
CC   -!- PTM: O-glycosylated on hydroxylated lysine residues. The O-linked
CC       glycan consists of a Glc-Gal disaccharide. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the fibrillar collagen family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00793}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L48440; AAA79780.1; -; mRNA.
DR   EMBL; K02804; AAA40919.1; -; mRNA.
DR   EMBL; M10613; AAA40920.1; -; Genomic_DNA.
DR   EMBL; X79816; CAA56213.1; -; mRNA.
DR   PIR; A05152; A05152.
DR   PIR; I60384; I60384.
DR   RefSeq; NP_037061.1; NM_012929.1.
DR   AlphaFoldDB; P05539; -.
DR   BioGRID; 247447; 1.
DR   IntAct; P05539; 1.
DR   STRING; 10116.ENSRNOP00000071077; -.
DR   GlyCosmos; P05539; 8 sites, No reported glycans.
DR   GlyGen; P05539; 8 sites.
DR   PhosphoSitePlus; P05539; -.
DR   PaxDb; 10116-ENSRNOP00000016044; -.
DR   ABCD; P05539; 18 sequenced antibodies.
DR   DNASU; 25412; -.
DR   GeneID; 25412; -.
DR   KEGG; rno:25412; -.
DR   UCSC; RGD:2375; rat.
DR   AGR; RGD:2375; -.
DR   CTD; 1280; -.
DR   RGD; 2375; Col2a1.
DR   eggNOG; KOG3544; Eukaryota.
DR   InParanoid; P05539; -.
DR   OrthoDB; 2970887at2759; -.
DR   PhylomeDB; P05539; -.
DR   Reactome; R-RNO-1442490; Collagen degradation.
DR   Reactome; R-RNO-1474244; Extracellular matrix organization.
DR   Reactome; R-RNO-1650814; Collagen biosynthesis and modifying enzymes.
DR   Reactome; R-RNO-186797; Signaling by PDGF.
DR   Reactome; R-RNO-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-RNO-2022090; Assembly of collagen fibrils and other multimeric structures.
DR   Reactome; R-RNO-216083; Integrin cell surface interactions.
DR   Reactome; R-RNO-3000171; Non-integrin membrane-ECM interactions.
DR   Reactome; R-RNO-3000178; ECM proteoglycans.
DR   Reactome; R-RNO-419037; NCAM1 interactions.
DR   Reactome; R-RNO-8874081; MET activates PTK2 signaling.
DR   Reactome; R-RNO-8948216; Collagen chain trimerization.
DR   PRO; PR:P05539; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005604; C:basement membrane; ISO:RGD.
DR   GO; GO:0005581; C:collagen trimer; ISO:RGD.
DR   GO; GO:0005585; C:collagen type II trimer; ISO:RGD.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IDA:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0031012; C:extracellular matrix; ISO:RGD.
DR   GO; GO:0005615; C:extracellular space; ISO:RGD.
DR   GO; GO:0030020; F:extracellular matrix structural constituent conferring tensile strength; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0042289; F:MHC class II protein binding; ISO:RGD.
DR   GO; GO:0048407; F:platelet-derived growth factor binding; ISO:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0043394; F:proteoglycan binding; ISO:RGD.
DR   GO; GO:0097065; P:anterior head development; ISO:RGD.
DR   GO; GO:0060348; P:bone development; ISO:RGD.
DR   GO; GO:0001502; P:cartilage condensation; ISO:RGD.
DR   GO; GO:0051216; P:cartilage development; IEP:RGD.
DR   GO; GO:0060351; P:cartilage development involved in endochondral bone morphogenesis; IEP:RGD.
DR   GO; GO:0071773; P:cellular response to BMP stimulus; ISO:RGD.
DR   GO; GO:1990314; P:cellular response to insulin-like growth factor stimulus; IEP:RGD.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IEP:RGD.
DR   GO; GO:0071316; P:cellular response to nicotine; IEP:RGD.
DR   GO; GO:0071374; P:cellular response to parathyroid hormone stimulus; IEP:RGD.
DR   GO; GO:0071375; P:cellular response to peptide hormone stimulus; IEP:RGD.
DR   GO; GO:0071300; P:cellular response to retinoic acid; IEP:RGD.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IEP:RGD.
DR   GO; GO:0071306; P:cellular response to vitamin E; IEP:RGD.
DR   GO; GO:0007417; P:central nervous system development; ISO:RGD.
DR   GO; GO:0002062; P:chondrocyte differentiation; IEP:RGD.
DR   GO; GO:0030199; P:collagen fibril organization; ISO:RGD.
DR   GO; GO:0060272; P:embryonic skeletal joint morphogenesis; ISO:RGD.
DR   GO; GO:0001958; P:endochondral ossification; ISO:RGD.
DR   GO; GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; ISO:RGD.
DR   GO; GO:0003417; P:growth plate cartilage development; IEP:RGD.
DR   GO; GO:0003007; P:heart morphogenesis; ISO:RGD.
DR   GO; GO:0048839; P:inner ear development; ISO:RGD.
DR   GO; GO:0042472; P:inner ear morphogenesis; ISO:RGD.
DR   GO; GO:0060174; P:limb bud formation; ISO:RGD.
DR   GO; GO:0035108; P:limb morphogenesis; ISO:RGD.
DR   GO; GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; ISO:RGD.
DR   GO; GO:0030903; P:notochord development; ISO:RGD.
DR   GO; GO:0001503; P:ossification; ISO:RGD.
DR   GO; GO:0071599; P:otic vesicle development; ISO:RGD.
DR   GO; GO:0006029; P:proteoglycan metabolic process; ISO:RGD.
DR   GO; GO:0010468; P:regulation of gene expression; ISO:RGD.
DR   GO; GO:0071774; P:response to fibroblast growth factor; IEP:RGD.
DR   GO; GO:0009612; P:response to mechanical stimulus; IEP:RGD.
DR   GO; GO:0010165; P:response to X-ray; IEP:RGD.
DR   GO; GO:0060021; P:roof of mouth development; ISO:RGD.
DR   GO; GO:0007605; P:sensory perception of sound; ISO:RGD.
DR   GO; GO:0001501; P:skeletal system development; ISO:RGD.
DR   GO; GO:0048705; P:skeletal system morphogenesis; ISO:RGD.
DR   GO; GO:0001894; P:tissue homeostasis; ISO:RGD.
DR   GO; GO:0007601; P:visual perception; ISO:RGD.
DR   Gene3D; 2.60.120.1000; -; 1.
DR   InterPro; IPR008160; Collagen.
DR   InterPro; IPR050149; Collagen_superfamily.
DR   InterPro; IPR000885; Fib_collagen_C.
DR   PANTHER; PTHR24023; COLLAGEN ALPHA; 1.
DR   PANTHER; PTHR24023:SF58; COLLAGEN ALPHA-1(II) CHAIN; 1.
DR   Pfam; PF01410; COLFI; 1.
DR   Pfam; PF01391; Collagen; 5.
DR   SMART; SM00038; COLFI; 1.
DR   PROSITE; PS51461; NC1_FIB; 1.
PE   1: Evidence at protein level;
KW   Calcium; Collagen; Disulfide bond; Extracellular matrix; Glycoprotein;
KW   Hydroxylation; Metal-binding; Reference proteome; Repeat; Secreted; Signal.
FT   SIGNAL          1..25
FT                   /evidence="ECO:0000255"
FT   PROPEP          26..113
FT                   /note="N-terminal propeptide"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000005735"
FT   CHAIN           114..1173
FT                   /note="Collagen alpha-1(II) chain"
FT                   /id="PRO_0000005736"
FT   CHAIN           1174..1419
FT                   /note="Chondrocalcin"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000043407"
FT   DOMAIN          1185..1419
FT                   /note="Fibrillar collagen NC1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00793"
FT   REGION          28..1168
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          133..1146
FT                   /note="Triple-helical region"
FT   REGION          1147..1173
FT                   /note="Nonhelical region (C-terminal)"
FT   COMPBIAS        64..80
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        88..105
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        364..378
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1132..1149
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         1233
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         1235
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         1236
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         1238
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         1241
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   SITE            113..114
FT                   /note="Cleavage; by procollagen N-endopeptidase"
FT                   /evidence="ECO:0000250"
FT   SITE            1173..1174
FT                   /note="Cleavage; by procollagen C-endopeptidase"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         122
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         219
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         231
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         240
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         306
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         540
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         552
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         591
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:21757687"
FT   MOD_RES         600
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:21757687"
FT   MOD_RES         602
FT                   /note="3-hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:21757687"
FT   MOD_RES         603
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:21757687"
FT   MOD_RES         606
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:21757687"
FT   MOD_RES         839
FT                   /note="3-hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:21757687"
FT   MOD_RES         840
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:21757687"
FT   MOD_RES         846
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:21757687"
FT   MOD_RES         852
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:21757687"
FT   MOD_RES         1076
FT                   /note="3-hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:21757687"
FT   MOD_RES         1113
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:21757687"
FT   MOD_RES         1118
FT                   /note="3-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:21757687"
FT   MOD_RES         1119
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:21757687"
FT   MOD_RES         1133
FT                   /note="3-hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:21757687"
FT   MOD_RES         1134
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:21757687"
FT   MOD_RES         1137
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:21757687"
FT   MOD_RES         1139
FT                   /note="3-hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:21757687"
FT   MOD_RES         1140
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:21757687"
FT   MOD_RES         1143
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:21757687"
FT   MOD_RES         1145
FT                   /note="3-hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:21757687"
FT   MOD_RES         1146
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:21757687"
FT   CARBOHYD        122
FT                   /note="O-linked (Gal...) hydroxylysine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        219
FT                   /note="O-linked (Gal...) hydroxylysine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        231
FT                   /note="O-linked (Gal...) hydroxylysine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        240
FT                   /note="O-linked (Gal...) hydroxylysine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        306
FT                   /note="O-linked (Gal...) hydroxylysine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        540
FT                   /note="O-linked (Gal...) hydroxylysine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        552
FT                   /note="O-linked (Gal...) hydroxylysine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        1320
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        1215..1247
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00793"
FT   DISULFID        1221
FT                   /note="Interchain (with C-1238)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00793"
FT   DISULFID        1238
FT                   /note="Interchain (with C-1221)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00793"
FT   DISULFID        1255..1417
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00793"
FT   DISULFID        1325..1370
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00793"
FT   CONFLICT        121
FT                   /note="E -> Q (in Ref. 2; AAA40919)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1419 AA;  134570 MW;  B7C63B77819CE50B CRC64;
     MIRLGAPQSL VLLTLLIATV LQCQGQDARK LGPKGQKGEP GDIKDIIGPK GPPGPQGPAG
     EQGPRGDRGD KGERGAPGPR GRDGEPGTPG NPGPPGPPGP PGPPGLGGGN FAAQMAGGFD
     EKAGGAQMGV MQGPMGPMGP RGPPGPAGAP GPQGFQGNPG EPGEPGVSGP IGPRGPPGPA
     GKPGDDGEAG KPGKAGERGL PGPQGARGFP GTPGLPGVKG HRGYPGLDGA KGEAGAPGVK
     GESGSPGENG SPGPMGPRGL PGERGRTGPA GAAGARGNDG QPGPAGPPGP VGPAGGPGFL
     GAPGAKGEAG PTGARGPEGA QGSRGEPGNP GSPGPAGASG NPGTDGIPGA KGSAGAPGIA
     GAPGFPGPRG PPGPQGATGP LGPKGQTGEP GIAGFKGEQG PKGETGPAGP QGAPGPAGEE
     GKRGARGEPG GAGPIGPPGE RGAPGNRGFP GQDGLAGPKG APGERGPSGL AGPKGANGDP
     GRPGEPGLPG ARGLTGRPGD AGPQGKVGPS GAPGEDGRPG PPGPQGARGQ PGVMGFPGPK
     GANGEPGKAG EKGLAGAPGL RGLPGKDGET GAAGPPGPSG PAGERGEQGA PGPSGFQGLP
     GPPGPPGEGG KQGDQGIPGE AGAPGLVGPR GERGFPGERG SPGAQGLQGP RGLPGTPGTD
     GPKGAAGPDG PPGAQGPPGL QGMPGERGAA GIAGPKGDRG DVGEKGPEGA PGKDGGRGLT
     GPIGPPGPAG ANGEKGEVGP PGPSGSTGAR GAPGERGETG PPGPAGFAGP PGADGQPGAK
     GDQGEAGQKG DAGAPGPQGP SGAPGPQGPT GVTGPKGARG AQGPPGATGF PGAAGRVGPP
     GSNGNPGPAG PPGPAGKDGP KGARGDTGAP GRAGDPGLQG PAGAPGEKGE PGDDGPSGSD
     GPPGPQGLAG QRGIVGLPGQ RGERGFPGLP GPSGEPGKQG APGASGDRGP PGPVGPPGLT
     GPAGEPGREG SPGADGPPGR DGAAGVKGDR GETGALGAPG APGPPGSPGP AGPTGKQGDR
     GEAGAQGPMG PSGPAGARGI AGPQGPRGDK GEAGEPGERG LKGHRGFTGL QGLPGPPGPS
     GDQGTSGPAG PSGPRGPPGP VGPSGKDGSN GIPGPIGPPG PRGRSGETGP AGPPGNPGPP
     GPPGPPGPGI DMSAFAGLGQ REKGPDPLQY MRADEADSTL RQHDVEVDAT LKSLNNQIES
     IRSPDGSRKN PARTCQDLKL CHPEWKSGDY WIDPNQGCTL DAMKVFCNME TGESCVYPNP
     ATVPRKNWWS SKSKEKKHIW FGETMNGGFH FSYGDGNLAP NTANVQMTFL RLLSTEGSQN
     ITYHCKNSIA YLDEAAGNLK KALLIQGSND VEMRAEGNSR FTYTALKDGC TKHTGKWGKT
     IIEYRSQKTS RLPIVDIAPM DIGGPDQEFG VDIGPVCFL
//
